Ibuprofen Market is Anticipated to Attain the Value of US$ 438.0 Mn by the end of 2025| QY Research, Inc

Ibuprofen is a derivative of propionic acid, which has major applications in treating inflammation. The drug is also prescribed by many physicians for reducing high fever. The usage of Ibuprofen as the pain-relief drug is rapidly evolving and further studies to know its usages in various applications are expected to be done which will offer new avenues for the growth of the market. An overview of the market is presented in a newly released report of QYR Consulting titled, “Ibuprofen Market Report Company Analysis, History, and Future Overview, Global Sales Trends by 2025,” which provides drivers and recent trends along with a detailed assessment of the market.

Segmental Analysis

Easy to Swallow Characteristic of Capsules to Augment the Growth of the Capsule Segment

By application is the key segment of the global ibuprofen market which is segmented into Suspension, Capsule, Tablet, and Others. The growing geriatric population suffering from various health issues such as arthritis, cancer, and back pain find easy to swallow capsules over tablets. This particular factor is propelling the growth of the capsule segment. Based on the product, the market is segmented into EP and USP.

Request a Sample of this report https://www.qyrconsulting.com/request-sample/7920

Regional Analysis

Asia-Pacific Region is likely to Emerge as the Fastest Growing Region of the Market

The Asia-Pacific region is likely to emerge as the fastest-growing region of the market due to the presence of a large number of patients suffering from chronic illnesses such as cancer, arthritis, and trauma. Robust growth in the healthcare sector along with growing awareness regarding health is expected to foster the growth of the market.

Key Players

Leading Companies are Keen to Develop New Facilities

Some of the leading companies profiled in the report are IOLCP, Xinhua Pharmaceutical, Strides Shasun, Granules Biocause, SI Group, BASF, Xinhua, Hisoa, and Perrigo Pharmaceutical. Market players are involved in developing production facilities and announcing collaboration and agreements along with strengthening the distribution network.

For instance, in 2018, Shandong Xinhua Pharmaceutical purchased three ibuprofen Abbreviated New drug applications in the U.S. from AiPing Pharmaceutical, Inc. and agreed to grant distribution right to Aiping in the U.S.

Get a Complete Market Report in your Inbox within 24 hours at https://www.qyrconsulting.com/checkout/7920

Market Dynamics

High Demand for Ibuprofen for the Treatment of Fever and Inflammation to Drive the Growth of the Market

The basic function of Ibuprofen is to reduce inflammation and fever. The growing prevalence of diseases such as arthritis, cancer, back pain, and the growing mental health conditions such as trauma has resulted in high demand for Ibuprofen. Ibuprofen is a Non-opioids drug that is available at an affordable price and offers a better alternative to opioid pain-killers.

Access Full Report Details at https://www.qyrconsulting.com/reports/ibuprofen-market

About QYR Consulting

QYR Consulting established as a research firm in 2007 and has since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for a wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.